Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 126Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 1863Lung Neoplasms 1292Small Cell Lung Carcinoma 324Colorectal Neoplasms 273Breast Neoplasms 242Melanoma 221Neoplasms 215Ovarian Neoplasms 192Neoplasm Metastasis 182Pancreatic Neoplasms 155Squamous Cell Carcinoma of Head and Neck 150Stomach Neoplasms 141Head and Neck Neoplasms 121Carcinoma, Renal Cell 119Triple Negative Breast Neoplasms 109Esophageal Neoplasms 108Prostatic Neoplasms 106Endometrial Neoplasms 98Uterine Cervical Neoplasms 96Urinary Bladder Neoplasms 87Colonic Neoplasms 87Mesothelioma 86Mesothelioma, Malignant 80Carcinoma, Hepatocellular 74Brain Neoplasms 70Sarcoma 63Disease 62Adenocarcinoma of Lung 59Carcinoma, Transitional Cell 54Gastrointestinal Neoplasms 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Solid Tumor × Thoracic × 1 year × Clear all
NCT06816108 2026-01-12

A Study of ONO-7428 in Participants With Unresectable Advanced or Recurrent Solid Tumors

Ono Pharmaceutical Co., Ltd.

Phase 1 Recruiting
60 enrolled
Other solid neoplasmThoracic

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡